PubRank

Christian Götting

Author PubWeight™ 60.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009 2.71
2 Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol 2009 1.92
3 Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. Am J Clin Nutr 2010 1.75
4 Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 2007 1.56
5 Circulating calcitriol concentrations and total mortality. Clin Chem 2009 1.38
6 SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin Chem 2007 1.33
7 Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006 1.31
8 Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 2005 1.15
9 Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin Chem 2007 1.14
10 Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail 2008 1.06
11 Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum. Hum Mol Genet 2009 1.05
12 Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans. J Biol Chem 2006 1.03
13 Mutational analysis of the ABCC6 gene and the proximal ABCC6 gene promoter in German patients with pseudoxanthoma elasticum (PXE). Hum Mutat 2006 0.99
14 A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program. Cardiovasc Diabetol 2009 0.98
15 The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin Biochem 2008 0.98
16 Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II. J Biol Chem 2006 0.98
17 Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 2009 0.97
18 Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy. Cell Transplant 2007 0.96
19 Quantitative determination of the glycosaminoglycan Delta-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography. J Chromatogr A 2008 0.93
20 Novel mutations in the ABCC6 gene of German patients with pseudoxanthoma elasticum. Hum Biol 2005 0.92
21 Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients identifies new candidates involved in PXE pathogenesis. Lab Invest 2008 0.92
22 Decorin GAG synthesis and TGF-β signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011 0.91
23 Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans. Biochem Biophys Res Commun 2009 0.89
24 New ABCC6 gene mutations in German pseudoxanthoma elasticum patients. J Mol Med (Berl) 2004 0.88
25 Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity. Biochem J 2005 0.88
26 Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. J Biol Chem 2007 0.86
27 Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry. Clin Chem 2006 0.86
28 Adiponectin decreases postprandially following a heat-processed meal in individuals with type 2 diabetes: an effect prevented by benfotiamine and cooking method. Diabetes Care 2007 0.85
29 Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Clin Biochem 2008 0.85
30 Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy. Kidney Int 2005 0.85
31 The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I. Stem Cells 2006 0.84
32 Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients. J Mol Med (Berl) 2009 0.83
33 High-level expression and purification of human xylosyltransferase I in High Five insect cells as biochemically active form. Biochem Biophys Res Commun 2003 0.83
34 The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes. Diabetes Care 2006 0.83
35 Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum. Clin Chim Acta 2010 0.82
36 Identification and characterization of the human xylosyltransferase I gene promoter region. J Biol Chem 2009 0.82
37 The xylosyltransferase Iota gene polymorphism c.343G>T (p.A115S) is associated with decreased serum glycosaminoglycan levels. Clin Biochem 2008 0.81
38 Fundus autofluorescence in Pseudoxanthoma elasticum. Retina 2009 0.81
39 Heterologous expression and biochemical characterization of soluble human xylosyltransferase II. Biochem Biophys Res Commun 2007 0.81
40 Quantitative determination and comparison of the glycosaminoglycan Delta-disaccharide composition in 22 different human cell lines. Cell Biol Int 2009 0.80
41 Age dependent assessment of TFPI levels in follicular fluid of women undergoing IVF. Clin Chim Acta 2005 0.80
42 Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatography. Thromb Res 2004 0.79
43 Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells. Matrix Biol 2007 0.79
44 Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann N Y Acad Sci 2008 0.79
45 Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors. Ann Hematol 2005 0.79
46 Increased serum xylosyltransferase activity in patients with liver fibrosis. Clin Chim Acta 2009 0.78
47 New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers. Front Genet 2013 0.78
48 Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Talanta 2009 0.78
49 Characterization of the ATP-binding cassette transporter gene expression profile in Y79: a retinoblastoma cell line. Mol Cell Biochem 2009 0.78
50 Human xylosyltransferase I and N-terminal truncated forms: functional characterization of the core enzyme. Biochem J 2006 0.78
51 First in-gel detection and purification of human xylosyltransferase II. Biochem Biophys Res Commun 2008 0.78
52 Centrifugal fundus abnormalities in pseudoxanthoma elasticum. Ophthalmology 2010 0.78
53 First identification and functional analysis of the human xylosyltransferase II promoter. Glycoconj J 2012 0.78
54 Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins. Diabetes Care 2012 0.77
55 Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro. Thromb Res 2006 0.77
56 ABCC6- a new player in cellular cholesterol and lipoprotein metabolism? Lipids Health Dis 2014 0.77
57 High xylosyltransferase activity in children and during mineralization of osteoblast-like SAOS-2 cells. Glycoconj J 2008 0.77
58 A novel ultra-sensitive method for the quantification of glycosaminoglycan disaccharides using an automated DNA sequencer. Electrophoresis 2006 0.76
59 Elevated serum levels of intercellular adhesion molecule ICAM-1 in Pseudoxanthoma elasticum. Clin Chim Acta 2008 0.76
60 Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes. Clin Chim Acta 2008 0.76
61 Determination of beta4-galactosyltransferase-7 activity using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Clin Biochem 2008 0.76
62 Involvement of a cysteine protease in the secretion process of human xylosyltransferase I. Glycoconj J 2010 0.76
63 Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers. Int J Vasc Med 2012 0.75
64 Rapid micro-scale assay for homocysteine by liquid chromatography-tandem mass spectrometry. Clin Biochem 2005 0.75
65 Does evidence exist for the presence of UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase I orthologs in Pseudomonas fluorescens? J Biotechnol 2007 0.75
66 Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography-tandem mass spectrometry assay. J Pharm Biomed Anal 2009 0.75
67 Analysis of xylosyltransferase II binding to the anticoagulant heparin. Biochem Biophys Res Commun 2009 0.75
68 High-density tissue-like cultivation of JAR choriocarcinoma cells for the in vitro production of human xylosyltransferase. J Biotechnol 2003 0.75
69 Serum xylosyltransferase I activity, the new biochemical fibrosis marker, is not affected by renal insufficiency. Clin Biochem 2005 0.75
70 Elevated TFPI levels in female hyperhomocysteinemic patients. Clin Biochem 2005 0.75
71 Xylosyltransferase gene variants and their role in essential hypertension. Am J Hypertens 2009 0.75
72 Expression and characterization of wild-type TFPI and the [P151L]TFPI mutant in insect cells. Mol Cell Biochem 2006 0.75
73 Xylosyltransferase I acceptor properties of fibroblast growth factor and its fragment bFGF (1-24). Biochem Biophys Res Commun 2005 0.75
74 Pseudoxanthoma elasticum-like fibers in the inflamed skin of patients without pseudoxanthoma elasticum. J Cutan Pathol 2007 0.75